Key result
Troponin elevation ratio >3.15 best identifies acute MI, which drives ~73% of troponin elevations.
Observational (n=150)
Yes
Objectives: To determine the prevalence of acute myocardial infarction (AMI) and other etiologies in patients with elevated troponin, to associate troponin values with the etiology, and to define the optimal cut-off point to differentiate AMI from other causes.Methods: All patients with elevated troponin who were hospitalized within 1 year and registered in the REGIBAR study were included.Magnitude was analyzed with the highest dose value/baseline value.The ROC curve and the Youden index were used to determine the optimal cut-off point.Results: A total of 150 cases were included (age: 66.3 13.8 years, 71% male); 109 AMI (age: 71.1 years, 63.5% male), 18 (12%) with other cardiac causes, 15 (10%) with non-cardiac causes, and 8 (5.3%) with no evident etiology.The optimal cut-off point for troponin dose/baseline value to discriminate AMI was > 3.15.Conclusions: A 73% of inpatients with elevated troponin were AMI cases (> 3.15 times the cut-off point).Heart failure was the second most common cause of elevated troponin.
No takes yet. Share an insight, caveat, or question.
Bocian et al. (2021) conducted an observational in Elevated troponin (n=150). Elevated troponin magnitude (highest dose/baseline ratio) vs. Other causes of troponin elevation was evaluated on Prevalence of acute myocardial infarction and optimal cut-off point for discrimination. A troponin elevation ratio >3.15 optimally discriminated acute myocardial infarction, which accounted for 73% of all hospitalized patients with elevated troponin.
Synapse has enriched 4 related papers. Consider them for comparative context: